Everquest Capital Partners takes 0.4% stake in Qkine, life-science protein firm
Published
Everquest Capital Partners entered Qkine Limited’s register with 18,230 ordinary shares, representing a 0.4% stake in the company. No other corporate, fund, trust or nominee entry or exit is reported. Anthemic LLC and O2H Nominees Limited also increased their ordinary holdings, while the register’s total shares rose. The filing date is 10 June 2026, covering 1 June 2025 to 1 June 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | EVERQUEST CAPITAL PARTNERS | 18,230 | — | ORDINARY 18,230 |
Current shareholders (13)
| Shareholder | Total shares | Share classes |
|---|---|---|
| THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE | 267,317 | ORDINARY 267,317 |
| MARTLET CAPITAL LIMITED | 229,096 | ORDINARY 229,096 |
| ANTHEMIC LLC | 221,055 | ORDINARY 221,055 |
| DOWNING HEALTHCARE KNOWLEDGE INTENSIVE EIS FUND | 217,873 | ORDINARY 217,873 |
| O2H NOMINEES LIMITED | 131,835 | ORDINARY 131,835 |
| THAMES VENTURES 2 VCT PLC (DOWNING VCT FUNDS) | 131,755 | ORDINARY 131,755 |
| KCP NOMINEES LTD | 86,956 | ORDINARY 86,956 |
| CPI ENTERPRISES LTD | 63,317 | ORDINARY 63,317 |
| EVERQUEST CAPITAL PARTNERS | 18,230 | ORDINARY 18,230 |
| ZEPPELIN INVESTMENTS PTY LTD | 16,908 | ORDINARY 16,908 |
| DOWNING HEALTHCARE IMPACT EIS FUND | 15,587 | ORDINARY 15,587 |
| AUBIGNY INVESTMENTS PTY LTD | 13,526 | ORDINARY 13,526 |
| WATSON'S BAY INVESTMENTS PTY LTD | 12,077 | ORDINARY 12,077 |
Contact the editorial team at editorial@fundingspotter.com